Publications by authors named "Longwang Lin"

Claim this Profile
S
Should transarterial chemoembolization be applied with systemic therapy for hepatocellular carcinoma with hepatic vein and/or inferior vena cava tumor thrombus (CHANCE2505)?: a multicenter study.
Long-Wang Lin, Qian Chen, Hong-Tao Hu, Guan-Hui Zhou, Zhi-Cheng Jin

Int J Surg· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The METAL Score for Early Stratification of Radiological Response and Survival in Hepatocellular Carcinoma Treated with TACE and Immunotherapy Combinations.
Qian Chen, Long-Wang Lin, Zhi-Cheng Jin, Bin Xiong, Hong-Tao Hu

Acad Radiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Transarterial Chemoembolization Combined with Lenvatinib Plus Programmed Death-1 Inhibitor for Hepatocellular Carcinoma with the Hepatic Vein and/or Inferior Vena Cava Tumor Thrombus.
Long-Wang Lin, Yu-Xia Nian, Xin Lin, Kun Ke, Wei-Zhu Yang, Jun-Qing Lin

Cardiovasc Intervent Radiol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased Expression of CD74 in Atherosclerosis Associated with Inflammatory Responses of Endothelial Cells and Macrophages.
Kun Ke, Zhengzhong Wu, Junqing Lin, Longwang Lin, Ning Huang

Biochem Genet· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of transarterial chemoembolization combined with lenvatinib, programmed death-1 inhibitor, and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombosis.
Long-Wang Lin, Le-Ye Yan, Kun Ke, Wei-Zhu Yang, Jun-Qing Lin

Brachytherapy· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of biliary stenting combined with iodine-125 seed strand followed by hepatic artery infusion chemotherapy plus lenvatinib with PD-1 inhibitor for the treatment of extrahepatic cholangiocarcinoma with malignant obstructive jaundice.
Long-Wang Lin, Kun Ke, Rong Chen, Wei-Zhu Yang, Ning Huang

Front Immunol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of hepatic artery infusion chemotherapy combined with tyrosine kinase inhibitors plus programmed death-1 inhibitors for hepatocellular carcinoma refractory to transarterial chemoembolization.
Long-Wang Lin, Kun Ke, Le-Ye Yan, Rong Chen, Jing-Yao Huang

Front Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis